Beta Drugs Financial Statements

Beta Drugs Annually Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 - -
Growth matrix (%)        
Revenue growth 27.90 -- -- --
Op profit growth 38.20 -- -- --
EBIT growth 26.20 -- -- --
Net profit growth 24.50 -- -- --
Profitability ratios (%)        
OPM 21.30 19.70 -- --
EBIT margin 15.80 16 -- --
Net profit margin 10.10 10.40 -- --
RoCE 22.20 -- -- --
RoNW 4.66 -- -- --
RoA 3.54 -- -- --
Per share ratios ()        
EPS 12.20 9.79 -- --
Dividend per share -- -- -- --
Cash EPS 5.05 5.88 -- --
Book value per share 71.40 59.40 -- --
Valuation ratios        
P/E 9.84 4.09 -- --
P/CEPS 23.80 6.80 -- --
P/B 1.68 0.67 -- --
EV/EBIDTA 4.85 3.04 -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (26) (21) -- --
Liquidity ratios        
Debtor days 103 -- -- --
Inventory days 44.60 -- -- --
Creditor days (76) -- -- --
Leverage ratios        
Interest coverage (7.60) (5.60) -- --
Net debt / equity 0.10 0.30 -- --
Net debt / op. profit 0.28 0.96 -- --
Cost breakup ()        
Material costs (51) (49) -- --
Employee costs (9.40) (10) -- --
Other costs (19) (21) -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 - -
Revenue 116 90.80 -- --
yoy growth (%) 27.90 -- -- --
Raw materials (59) (44) -- --
As % of sales 50.60 48.80 -- --
Employee costs (11) (9.50) -- --
As % of sales 9.37 10.40 -- --
Other costs (22) (19) -- --
As % of sales 18.70 21 -- --
Operating profit 24.70 17.90 -- --
OPM 21.30 19.70 -- --
Depreciation (6.90) (3.80) -- --
Interest expense (2.40) (2.60) -- --
Other income 0.50 0.41 -- --
Profit before tax 16 12 -- --
Taxes (4.20) (2.60) -- --
Tax rate (26) (21) -- --
Minorities and other -- -- -- --
Adj. profit 11.70 9.42 -- --
Exceptional items -- -- -- --
Net profit 11.70 9.42 -- --
yoy growth (%) 24.50 -- -- --
NPM 10.10 10.40 -- --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 - -
Profit before tax 16 12 -- --
Depreciation (6.90) (3.80) -- --
Tax paid (4.20) (2.60) -- --
Working capital 8.86 -- -- --
Other operating items -- -- -- --
Operating cashflow 13.70 -- -- --
Capital expenditure 2.85 -- -- --
Free cash flow 16.60 -- -- --
Equity raised 94.80 -- -- --
Investments 0.43 -- -- --
Debt financing/disposal (5.10) -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 107 -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 9.61 9.61 8.65 8.65
Preference capital -- -- -- --
Reserves 59 47.50 32.30 24.20
Net worth 68.60 57.10 40.90 32.90
Minority interest
Debt 17.50 22.60 20 7.50
Deferred tax liabilities (net) -- -- 0.15 0.15
Total liabilities 86.10 79.70 61 40.50
Fixed assets 42.80 43.90 32.40 14.50
Intangible assets
Investments 0.78 0.35 0.35 --
Deferred tax asset (net) 0.65 0.17 0.29 --
Net working capital 31.40 29.90 24.70 14.10
Inventories 16 12.40 9.53 2.80
Inventory Days 50.40 49.60 -- --
Sundry debtors 33.90 31.90 25 14.40
Debtor days 106 128 -- --
Other current assets 13 13.10 11.80 5.89
Sundry creditors (22) (16) (16) (6.10)
Creditor days 67.80 65.70 -- --
Other current liabilities (9.90) (11) (6.10) (3)
Cash 10.40 5.39 3.30 11.90
Total assets 86.10 79.70 61 40.50
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2021 Mar-2020 Mar-2019 - -
Gross Sales 116 90.80 65.90 -- --
Excise Duty -- -- -- -- --
Net Sales 116 90.80 65.90 -- --
Other Operating Income -- -- -- -- --
Other Income 0.50 0.41 0.37 -- --
Total Income 117 91.20 66.30 -- --
Total Expenditure ** 91.40 72.90 54.10 -- --
PBIDT 25.20 18.30 12.20 -- --
Interest 2.42 2.59 1.43 -- --
PBDT 22.80 15.70 10.80 -- --
Depreciation 6.87 3.76 2.84 -- --
Minority Interest Before NP -- -- -- -- --
Tax 4.71 2.51 1.69 -- --
Deferred Tax (0.50) 0.05 (1.80) -- --
Reported Profit After Tax 11.70 9.42 8.04 -- --
Minority Interest After NP -- -- -- -- --
Net Profit after Minority Interest 11.70 9.42 8.04 -- --
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 11.70 9.42 8.04 -- --
EPS (Unit Curr.) 12.20 9.93 9.30 -- --
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 9.61 9.61 8.65 -- --
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 21.70 20.20 18.50 -- --
PBDTM(%) 19.70 17.30 16.30 -- --
PATM(%) 10.10 10.40 12.20 -- --
Open ZERO Brokerage Demat Account